TNSN87045A1 - Procede de preparation d'inhibiteurs de l'enzyme de conversion de l'angiotensine - Google Patents

Procede de preparation d'inhibiteurs de l'enzyme de conversion de l'angiotensine

Info

Publication number
TNSN87045A1
TNSN87045A1 TNTNSN87045A TNSN87045A TNSN87045A1 TN SN87045 A1 TNSN87045 A1 TN SN87045A1 TN TNSN87045 A TNTNSN87045 A TN TNSN87045A TN SN87045 A TNSN87045 A TN SN87045A TN SN87045 A1 TNSN87045 A1 TN SN87045A1
Authority
TN
Tunisia
Prior art keywords
preparation
enzyme inhibitors
conversion enzyme
angiotensin conversion
angiotensin
Prior art date
Application number
TNTNSN87045A
Other languages
English (en)
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of TNSN87045A1 publication Critical patent/TNSN87045A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/022—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2
    • C07K5/0222—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2 with the first amino acid being heterocyclic, e.g. Pro, Trp
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Abstract

UN PROCEDE DE PREPARATION D'INHIBITEURS D'ACE
TNTNSN87045A 1986-03-27 1987-03-27 Procede de preparation d'inhibiteurs de l'enzyme de conversion de l'angiotensine TNSN87045A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19863610391 DE3610391A1 (de) 1986-03-27 1986-03-27 Verbindungen mit nootroper wirkung, diese enthaltende mittel und deren verwendung bei der behandlung und prophylaxe cognitiver dysfunktionen

Publications (1)

Publication Number Publication Date
TNSN87045A1 true TNSN87045A1 (fr) 1990-01-01

Family

ID=6297417

Family Applications (1)

Application Number Title Priority Date Filing Date
TNTNSN87045A TNSN87045A1 (fr) 1986-03-27 1987-03-27 Procede de preparation d'inhibiteurs de l'enzyme de conversion de l'angiotensine

Country Status (25)

Country Link
EP (1) EP0243645B1 (fr)
JP (1) JPS62240698A (fr)
KR (1) KR870008841A (fr)
CN (1) CN1031267C (fr)
AT (1) ATE102954T1 (fr)
AU (1) AU621278B2 (fr)
CA (1) CA1341064C (fr)
CS (2) CS212687A3 (fr)
DD (1) DD280765A5 (fr)
DE (2) DE3610391A1 (fr)
DK (1) DK172221B1 (fr)
EG (1) EG18175A (fr)
ES (1) ES2061447T3 (fr)
FI (1) FI91876C (fr)
HU (2) HU202118B (fr)
IE (1) IE62456B1 (fr)
MA (1) MA20919A1 (fr)
NO (1) NO178546C (fr)
NZ (1) NZ219764A (fr)
OA (1) OA08506A (fr)
PH (1) PH27210A (fr)
PT (1) PT84564B (fr)
RU (1) RU1836335C (fr)
TN (1) TNSN87045A1 (fr)
ZA (1) ZA872230B (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5231084A (en) * 1986-03-27 1993-07-27 Hoechst Aktiengesellschaft Compounds having a cognition adjuvant action, agents containing them, and the use thereof for the treatment and prophylaxis of cognitive dysfuncitons
US4743450A (en) * 1987-02-24 1988-05-10 Warner-Lambert Company Stabilized compositions
AU612137B2 (en) * 1987-04-27 1991-07-04 E.R. Squibb & Sons, Inc. Method for inhibiting loss of cognitive functions employing an ace inhibitor
DE3731085A1 (de) * 1987-09-16 1989-04-06 Hoechst Ag Neue aminosaeureester, verfahren zu ihrer herstellung, sie enthaltende arzneimittel und deren verwendung
DE3739690A1 (de) * 1987-11-24 1989-06-08 Hoechst Ag Stabilisierte arzneistoffe, verfahren zu ihrer herstellung sowie stabile arzneizubereitungen
DE3801587A1 (de) * 1988-01-21 1989-08-03 Hoechst Ag Neue aminosaeureglyceride, verfahren zu ihrer herstellung, sie enthaltende arzneimittel und deren verwendung
EP0331609A3 (fr) * 1988-01-27 1992-07-01 Hoechst Aktiengesellschaft Inhibiteurs de l'enzyme de conversion à activité psychotrope
DE3803225A1 (de) * 1988-02-04 1989-08-17 Hoechst Ag Aminosaeureamide mit psychotroper wirkung, verfahren zu ihrer herstellung, sie enthaltende mittel und deren verwendung
JPH01275529A (ja) * 1988-03-21 1989-11-06 E R Squibb & Sons Inc 晩発性運動障害の抑制治療剤
US5037821A (en) * 1988-06-01 1991-08-06 E. R. Squibb & Sons, Inc. Method for inhibiting loss of cognitive functions employing a calcium channel blocker alone or in combination with an ACE inhibitor
US5093129A (en) * 1989-01-30 1992-03-03 E. R. Squibb & Sons, Inc. Method for treating addiction to a drug of abuse employing an ace inhibitor
US5032578A (en) * 1990-09-17 1991-07-16 E. R. Squibb & Sons, Inc. Method for preventing or treating depression employing a combination of an ace inhibitor and a drug that acts at serotonin receptors
EP1372620A2 (fr) * 2001-03-15 2004-01-02 Saegis Pharmaceuticals Methodes permettant de retablir la fonction cognitive suite a un stress systemique

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3174844D1 (en) * 1980-10-23 1986-07-24 Schering Corp Carboxyalkyl dipeptides, processes for their production and pharmaceutical compositions containing them
DE3300774A1 (de) * 1983-01-12 1984-07-12 Hoechst Ag, 6230 Frankfurt Neue spirocyclische aminosaeuren, verfahren zu ihrer herstellung, diese enthaltende mittel und deren verwendung sowie neue spirocyclische aminosaeuren als zwischenprodukte und verfahren zu deren herstellung

Also Published As

Publication number Publication date
MA20919A1 (fr) 1987-10-01
NO871282D0 (no) 1987-03-26
CN87102304A (zh) 1987-12-30
CS276179B6 (en) 1992-04-15
OA08506A (fr) 1988-07-29
IE62456B1 (en) 1995-02-08
CS276385B6 (en) 1992-05-13
RU1836335C (ru) 1993-08-23
FI91876B (fi) 1994-05-13
ZA872230B (en) 1987-09-21
HU203117B (en) 1991-05-28
ES2061447T3 (es) 1994-12-16
DK153587A (da) 1987-09-28
CN1031267C (zh) 1996-03-13
EP0243645A3 (en) 1990-01-24
DE3789330D1 (de) 1994-04-21
ATE102954T1 (de) 1994-04-15
DK153587D0 (da) 1987-03-26
PH27210A (en) 1993-05-04
FI871304A (fi) 1987-09-28
NO178546B (no) 1996-01-08
CS651989A3 (en) 1992-05-13
HUT46046A (en) 1988-09-28
JPS62240698A (ja) 1987-10-21
PT84564A (de) 1987-04-01
EP0243645A2 (fr) 1987-11-04
CA1341064C (fr) 2000-08-01
EP0243645B1 (fr) 1994-03-16
DK172221B1 (da) 1998-01-12
HU202118B (en) 1991-02-28
HU896609D0 (en) 1990-02-28
AU7064987A (en) 1987-10-01
NZ219764A (en) 1990-11-27
EG18175A (en) 1994-07-30
DD280765A5 (de) 1990-07-18
KR870008841A (ko) 1987-10-21
PT84564B (pt) 1989-11-10
FI871304A0 (fi) 1987-03-25
DE3610391A1 (de) 1987-10-08
CS212687A3 (en) 1992-04-15
AU621278B2 (en) 1992-03-12
NO871282L (no) 1987-09-28
FI91876C (fi) 1994-08-25
NO178546C (no) 1996-04-17
IE870784L (en) 1987-09-27

Similar Documents

Publication Publication Date Title
IL104154A0 (en) Saccharin derivatives,their preparation and pharmaceutical compositions containing them
HUT43582A (en) Process for production of derivatives of 4,5,6-substituated-n-/substituated phenil/-piramidin-amin and medical compounds containing thereof
HUT68391A (en) Heterocyclic compounds substituted with side chain containing thio and carbonyl-amino-groups, pharmaceutical preparations containing said compounds as dual action inhibitors and process for preparing them
MX9803753A (es) Acidos alfa-iminohidroxamicos y -carboxilicos n-sustituidos ciclicos y heterociclicos.
TNSN87045A1 (fr) Procede de preparation d'inhibiteurs de l'enzyme de conversion de l'angiotensine
NO890259L (no) Fremgangsmaate for fremstilling av terapeutisk aktive etylfenoksyacetamider.
EP0219782A3 (en) Use of angiotensin-converting enzyme inhibitors in the treatment of atherosclerosis, thrombosis and peripheral vascular disease
MY104942A (en) Antiviral tetrahydroimidazo [1,4] benzodiazepin-2-ones.
DE68925173D1 (de) 4-Methyl und 4-Ethyl substituierte Pyrrolidin-2-one
ATE75399T1 (de) Therapeutikum zur behandlung von magengeschwueren.
CA1268468C (fr) Analogues des prostaglandines avec groupement thiabicycloheptane substitue
DE3662099D1 (en) Saturated cycloalkylûc¨pyrrole-2(1h)-acetic acid amides and derivatives thereof
PT88242A (pt) Processo para a preparacao de eteres e tioeteres tendo actividade terapeutica
DE3685988D1 (de) Verwendung von "naftidrofuryl" zur behandlung von neuropathien.